Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,580.00
+9.00 (0.57%)
Oct 2, 2026, 4:35 PM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.28 billion as of October 2, 2026. Its market cap has decreased by -17.42% in one year.
Market Cap
3.28B
Enterprise Value
4.55B
Revenue
2.58B
Ranking
n/a
PE Ratio
11.86
Stock Price
1,580.00
ChartMarket Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.28B, an increase of 598.97%. That is a compound annual growth rate of 9.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 3.28B | -4.37% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.97B |
| HUTCHMED (China) | 1.82B |
| Allergy Therapeutics | 300.80M |
| ECO Animal Health Group | 66.40M |
| Shield Therapeutics | 58.42M |
| Provexis | 21.11M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 915.12K |